FDC's Profitability Surges in Q1, Marking a Strong Sequential Recovery
FDC's Q1 profit jumped 8% year-on-year, outpacing modest revenue growth as net profit margin expanded to a healthy 20.2%.
FDC reported a solid Q1 FY27 with profit growth of 8% YoY, significantly outpacing a 2% revenue increase. The company's net profit margin expanded to 20.2%, showing improved operational efficiency.
FDC Limited delivered a strong start to FY27, with profit growth significantly outpacing revenue and profitability reaching a robust level. The pharmaceutical company's net profit for the June quarter rose 8% year-on-year to ₹132 crore, even as revenue grew a more modest 2% to ₹655 crore. This performance highlights a meaningful improvement in operational efficiency and cost management.
The sequential improvement from the previous quarter was even more pronounced. Revenue surged 16.1% and profit jumped 23.3% from the March 2026 quarter. This momentum helped push the net profit margin to 20.2%, up from 19.0% a year ago and 19.0% in the prior quarter. The results mark a clear recovery from a softer period in the middle of last fiscal year.
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin (%)
| Metric | CurrentQ1 FY27 | PreviousQ4 FY26 | Same quarter LYQ1 FY26 |
|---|---|---|---|
| Revenue (₹ Cr) | 655.1YoY +2% | 564.36 | 642.28 |
| Profit (₹ Cr) | 132.02YoY +8% | 107.07 | 122.20 |
| Net Profit Margin (%) | 20.2YoY +6.3% | 19.0 | 19.0 |
Key Points
- The company maintains a rock-solid balance sheet with zero debt.
- Return on Capital Employed (ROCE) stands at a healthy 16.52%.
- The stock trades at a P/E of 24.1, a notable discount to the industry average of 37.2.
Despite the strong quarterly earnings, the stock has faced headwinds, declining 22% over the past year. The current valuation discount to the sector suggests the market may be overlooking the company's improving profitability and pristine financial health. The key question is whether this quarter's margin strength can be sustained to drive a re-rating.
Live Chart
· FDC
(BSE)
ISIN: INE258B01022
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.